AJU IB Investment Co., Ltd. Long-Term Concentrated

CIK: 0001710065 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 6, 2025

Total Value ($000): $115,120 (100.0% shares, 0.0% debt)

Holdings (7)

ACLX ARCELLX INC 74.7%

Value ($000) $86,004 Shares 1,047,557 Est. Cost $16.72 Unrealized +330.6%

KYMR KYMERA THERAPEUTICS INC 22.5%

Value ($000) $25,865 Shares 457,059 Est. Cost $48.78 Unrealized -7.5%

SEER SEER INC 1.6%

Value ($000) $1,804 Shares 816,375 Est. Cost $63.62 Unrealized -96.7%

XLO XILIO THERAPEUTICS INC 0.5%

Value ($000) $596 Shares 667,742 Est. Cost $17.03 Unrealized -95.8%

— RALLYBIO CORP 0.3%

Value ($000) $377 Shares 754,678 Est. Cost $9.54 Unrealized —

— RAPT THERAPEUTICS INC 0.3%

Value ($000) $321 Shares 12,437 Est. Cost $19.75 Unrealized —

— SUTRO BIOPHARMA INC 0.1%

Value ($000) $153 Shares 175,000 Est. Cost $21.71 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACLX	ARCELLX INC	1,047,557	$86,004	74.7%	$16.72	+330.6%	COMMON STOCK	03940C100
KYMR	KYMERA THERAPEUTICS INC	457,059	$25,865	22.5%	$48.78	-7.5%	COM	501575104
SEER	SEER INC	816,375	$1,804	1.6%	$63.62	-96.7%	COM CL A	81578P106
XLO	XILIO THERAPEUTICS INC	667,742	$596	0.5%	$17.03	-95.8%	COM	98422T100
—	RALLYBIO CORP	754,678	$377	0.3%	$9.54	—	COM	75120L100
—	RAPT THERAPEUTICS INC	12,437	$321	0.3%	$19.75	—	COM NEW	75382E109
—	SUTRO BIOPHARMA INC	175,000	$153	0.1%	$21.71	—	COM	869367102